BioHarvest Sciences Sets May 14 Date for First-Quarter 2026 Results

The latest update is out from BioHarvest Sciences ( (BHST) ).

BioHarvest Sciences Inc. announced on April 30, 2026, that it will release its first quarter 2026 financial results before the market opens on Thursday, May 14, 2026. The company will host a conference call and live webcast at 8:00 a.m. U.S. Eastern Time that day, with a replay to be made available on its website, signaling ongoing efforts to engage investors and provide transparency around its operational progress.

The most recent analyst rating on (BHST) stock is a Buy with a $14.00 price target. To see the full list of analyst forecasts on BioHarvest Sciences stock, see the BHST Stock Forecast page.

Spark’s Take on BHST Stock

According to Spark, TipRanks’ AI Analyst, BHST is a Neutral.

The score is held down primarily by ongoing cash burn and lack of profitability, alongside weak technical trend signals (trading below key moving averages with negative MACD). Offsetting these risks, the latest earnings call pointed to strong revenue growth, improving margins/operating leverage, a much stronger cash position, and constructive 2026 targets (D2C profitability and higher CDMO revenue), which provide a meaningful—but not yet proven—upside catalyst.

To see Spark’s full report on BHST stock, click here.

More about BioHarvest Sciences

BioHarvest Sciences Inc. is a biotechnology company specializing in its proprietary Botanical Synthesis platform, which produces plant-based bioactive compounds without growing the whole plant. The company operates as both a contract development and manufacturing organization for clients seeking novel plant-derived ingredients and as a developer of proprietary nutraceutical and dietary supplement products focused on science-based, clinically supported health solutions.

Average Trading Volume: 23,442

Technical Sentiment Signal: Buy

Current Market Cap: $95.43M

For a thorough assessment of BHST stock, go to TipRanks’ Stock Analysis page.